Are you ready to bet a C-note at Wall Street’s huge casino? If so, feel free to give Bally’s (NYSE:BALY) stock a try. The company just completed a transaction with Gaming and Leisure Properties (NASDAQ:GLPI), which seems to favor Bally’s. On the other hand, don’t be too enthusiastic about Bally’s, as the company’s financials are
In my last article on Rivian Automotive (NASDAQ:RIVN), I argued that this electric vehicle stock appeared ready to crash. Not too long after that, RIVN stock entered “capitulation mode,” falling from the mid-$20s to the low-teens per share by year’s end. At first, it may have seemed as if this sell-off would come to an
For investors in a wide swath of companies, 2022 was a rough year. That said, it was a downright brutal year for those invested in most tech companies. Indeed, the three stocks on this list are among the mega-cap juggernauts of the tech world. With market capitalizations ranging from $335 billion to more than $2
A Biotech Company and an Under-The-Radar Cloud Transformation Stock to Round Out the Year Novavax, Inc. (NVAX) is a biotechnology company engaged in developing innovative vaccines to prevent serious infectious diseases. Novavax’s coronavirus vaccine, NVX-CoV2373, is currently approved for use in the European Union (EU), Indonesia and the Philippines. Regulatory applications seeking approval for the
The best vertical farming stocks have been in a deep correction mode. Unexpected weather conditions and shortage of water have affected the global agriculture industry. In the coming decades, the food crisis is likely to aggravate. As the world looks for a solution, vertical farming has gained traction because of its robust yield and significantly
In this article PERI-IL BMBL BKNG AAPL MSFT META AMZN DV Follow your favorite stocksCREATE FREE ACCOUNT Apple CEO Tim Cook poses in front of a new MacBook Airs running M2 chips display during Apple’s annual Worldwide Developers Conference in San Jose, California, June 6, 2022. Peter Dasilva | Reuters With the brutal 2022 behind
With many stocks discounted after a rough outing in 2022, market participants may want to concentrate on compelling blue-chip stocks to buy. The reason? Established players typically enjoy a long track record of success. Ahead of an ambiguous ecosystem (at best), large capitalization firms provide a measure of confidence. In addition, it’s much easier to
A look at two stocks for your aggressive growth radar screen. Harmonic: https://www.zacks.com/stock/quote/HLIT?cid=CS-YOUTUBE-FT-VID Enphase Energy: https://www.zacks.com/stock/quote/ENPH?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow us on Twitter: https://twitter.com/ZacksResearch Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
In this article SHOP-CA CAG STZ AMZN Follow your favorite stocksCREATE FREE ACCOUNT Signage outside a Bed Bath & Beyond retail store in New York, Aug. 25, 2022. Gabby Jones | Bloomberg | Getty Images Check out the companies making headlines in midday trading. Silvergate — Shares of the crypto-focused bank tumbled more than 42%
Fundamentally, the narrative for value stocks to buy in Jan. (or any other month) sells itself. Even the wealthiest among us find great deals attractive. Indeed, it takes a special kind of person to deliberately acquire something that’s overvalued for no good reason. As well, the wild market volatility in 2022 brings to the table amazing
After a bruising 2022, how will electric vehicle (EV) manufacturer Lucid Group (NASDAQ:LCID) treat its loyal investors during the next 12 months? It’s hard to envision a strong bull case for LCID stock as there no clear positive catalysts. Lucid did raise capital recently, but it wasn’t “free money” by any means. Moreover, the automaker’s
Shoppers line up outside a Costco to buy supplies after the Hawaii Department of Health on Wednesday advised residents they should stock up on a 14-day supply of food, water and other necessities for the potential risks of novel coronavirus in Honolulu, Hawaii, U.S. February 28, 2020. Courtesy of Duane Tanouye via REUTERS Check out
Stocks are getting cheaper in this down market, with the shares of many leading companies falling to distressed levels and sitting at or near fresh 52-week lows. The declines have created great buying opportunities, even for retail investors with only $250 to spend. Below, you will find a list of the five best stocks to
Meta Materials (NASDAQ:MMAT) stock was a popular meme play during 2021, falling off the radar of the investing public as the “meme craze” came to a close. However, in recent months, MMAT stock has again been making headlines in both a bad way and, more recently, in a good way. In December, the materials technology company
Dollar General: https://www.zacks.com/stock/quote/DG?cid=CS-YOUTUBE-FT-VID Dollar Tree: https://www.zacks.com/stock/quote/DLTR?cid=CS-YOUTUBE-FT-VID The dollar store corner of the retail market is one area that may actually be hurt by an improving economy. Can the space keep up the strong retail momentum this quarter though? Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on Facebook: www.facebook.com/ZacksInvestmentResearch
A “Now hiring” sign is displayed on the window of an IN-N-OUT fast food restaurant in Encinitas, California, May 9, 2022. Mike Blake | Reuters December’s strong job growth combined with slowing wage inflation is fueling optimism that the economy might just see a soft landing. But economists disagree on whether that will be the
Not every stock went down in 2022. Shares in some the biggest pharmaceutical companies rose in price. If you can make it in a market like 2022, imagine what can happen in 2023 for many top pharma stocks. What the best pharma stocks have in common is pricing power, patented medicines, big moats and wide margins.
Biotech stocks are in high demand right now, with good reason. Indeed, these biotech companies have the potential to revolutionize the medical world and offer solutions to unmet needs, while their relevance is recession-proof. With growing demand for gene therapies, immune oncology, and precision medicine, biotech companies have a unique opportunity to impact the world
Burton G. Malkiel, professor emeritus of economics at Princeton University, speaks at the John C. Bogle Legacy Forum in New York, U.S., on Tuesday, Jan. 31, 2012. Peter Foley | Bloomberg | Getty Images This week, Princeton professor Burton Malkiel has published the updated, 50th anniversary edition of A Random Walk Down Wall Street: the
In this article LULU BBBY WFC ULTA Follow your favorite stocksCREATE FREE ACCOUNT Chief Brand Officer and TV Personality of WWE, Stephanie McMahon delivers her keynote address at the opening of Sports Matters in conjunction with All That Matters 2016 in Singapore on September 14, 2016. Roslan Rahman | AFP | Getty Images Check out